You are here

Generic Celexa Receives FDA Approval

FORT LEE, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global generic pharmaceutical company, today announced that Purepac Pharmaceutical Co., a subsidiary of Alpharma, has received approval from the United States Food and Drug Administration ("FDA") for citalopram hydrobromide tablets,10 mg, 20 mg and 40 mg. This product is the generic equivalent of Celexa®, a product marketed by Forest Labs, for the treatment of depression with annual brand sales of approximately $1.4 billion. Alpharma will commence an immediate launch of this product.

This is the fourth FDA product approval that the company has received for products manufactured at the company's Elizabeth site since the FDA concluded an inspection at this site.

Alpharma press releases are also available at our website: http://www.alpharma.com/.

Source: Alpharma

Recent Headlines

Triggers the Body’s Own Natural Blood Flow Regulation
Inrebic Reduces Symptoms by 50% in Some Patients
Novel Catheter-based Technology for Treating Acute Ischemic Stroke
Decision supported by data from more than 4,000 patients
Statistically Significant Improvement in Excessive Daytime Sleepiness
Researcher Made Himself Guinea Pig to Test the Drug
Treatment Shorter, Less Complicated Than Typical Regimen
Zip Device Faster to Apply, Minimizes Scarring